Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

56%

5 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

4(50.0%)

N/A

3(37.5%)

Phase 3

1(12.5%)

8Total

Phase 4(4)

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03324932Phase 3Active Not Recruiting

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

Role: lead

NCT01384617Not ApplicableCompleted

Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy

Role: collaborator

NCT00334724Phase 4Withdrawn

Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study

Role: collaborator

NCT00863980Not ApplicableTerminated

Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

Role: lead

NCT00149227Phase 4Completed

Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

Role: lead

NCT00711919Not ApplicableUnknown

Pitavastatin on Carotid Intima-media Thickness

Role: lead

NCT00718926Unknown

The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients

Role: collaborator

NCT00423020Phase 4Unknown

Anti-Restenosis After AMI by Erythropoietin

Role: lead

NCT00276445Phase 4Terminated

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan

Role: collaborator

All 9 trials loaded